On 18 April 2026, President Trump signed the Executive Order ‘Accelerating medical treatments for serious mental illness’, which directs federal agencies to speed up research, regulatory review, and access pathways for psychedelic therapies. Brevia Health has examined the scope of the Executive Order, the potential timeline of these developments and how this could impact the UK.
Discover the impact of the MHRA and NICE’s new aligned pathway on medicine approval timelines in England.
The Government’s landmark 10 Year Health Plan for England, “Fit for the Future”, was published on 3 July 2025. The Plan aims to create a new model of care, building on the NHS’ founding principles and redesigning how the NHS delivers so that patients have real choice and control over their care.
NICE announced on 9 February 2026 the launch of its new National HealthTech Access Programme (NHAP). The NHAP is set to expand NICE’s technology appraisals programme to incorporate health technologies.
The Government published the long-awaited National Cancer Plan for England on 4 February 2026. The Plan sets out how DHSC and the NHS, will improve cancer prevention, diagnosis, treatment and research across England.
Brevia Health has been awarded the Best Healthcare Public Affairs & Market Access Consultancy in 2025.
